The first three patients have been dosed in a Phase 2a clinical trial investigating Annovis Bio‘s lead compound…
Articles by Inês Martins, PhD
The U.S. Food and Drug Administration (FDA) has accepted and given priority review designation to Biogen‘s application…
Biogen is pushing back the submission of aducanumab, its investigational treatment for Alzheimer’s disease, to the U.S.
A variety of shark species from the Atlantic and Pacific Oceans have high concentrations of two toxins linked to neurodegenerative…
Regular physical activity, normal body mass index (BMI), and a healthy diet may prevent the onset of Alzheimer’s disease by…
A new immunotherapy targeting apolipoprotein E4 (apoE4), a genetic variant of apolipoprotein E that increases the risk of early onset…
A single oral dose of methylene blue is able to increase the response of brain regions that control attention and short-term memory,…
Chocolate consumption may protect older people from cognitive decline, possibly preventing the development of Alzheimer’s disease, according to Portuguese researchers at…
Unbalanced, unhealthy zinc levels show in many diseases including Alzheimer’s disease, Parkinson’s disease, and pancreatic cancer. But lack of information about the molecular structure of…
The major genetic risk factor for Alzheimer’s disease (AD), the apolipoprotein E4 gene, is responsible for the disruption of a…